Drug Shortage Report for SUTENT
| Report ID | 159958 |
| Drug Identification Number | 02280817 |
| Brand name | SUTENT |
| Common or Proper name | SUTENT |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUNITINIB |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 28's |
| ATC code | L01EX |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-04 |
| Estimated end date | 2022-07-08 |
| Actual end date | 2022-06-07 |
| Shortage status | Resolved |
| Updated date | 2022-06-08 |
| Company comments | On preventive allocation. 12.5mg & 25mg Strengths available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-06-08 | French | Compare |
| v5 | 2022-06-08 | English | Compare |
| v4 | 2022-06-08 | English | Compare |
| v3 | 2022-05-05 | English | Compare |
| v2 | 2022-05-04 | French | Compare |
| v1 | 2022-05-04 | English | Compare |
Showing 1 to 6 of 6